Paradigm Biopharmaceuticals Ltd. (AU:PAR) has released an update.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Paradigm Biopharmaceuticals Ltd. recently announced a change in director Donna Skerrett’s interest, as she disposed of 1,000,000 performance rights. Despite this disposal, Skerrett maintains her holding of 1,094,284 fully paid ordinary shares in the company. The change reflects a lapse in conditional rights under the Employee Performance Rights Plan.
For further insights into AU:PAR stock, check out TipRanks’ Stock Analysis page.
